Patents for C12R 1 - Micro-organisms (92,025) |
---|
05/11/1994 | CA2147617A1 Medium-chain thioesterases in plants |
05/11/1994 | CA2147598A1 Op-3-induced morphogenesis |
05/11/1994 | CA2147496A1 Assay for inhibitors of farnesyl-protein transferase |
05/11/1994 | CA2147252A1 Rna packaging system |
05/11/1994 | CA2146926A1 Conjugate vaccine against group b streptococcus |
05/11/1994 | CA2146559A1 Methods of preparing soluble, oligomeric proteins |
05/11/1994 | CA2146556A1 Enantioselective production of chiral carboxylic acids |
05/11/1994 | CA2127283A1 Urease-based vaccine against helicobacter infection |
05/11/1994 | CA2120131A1 Expression and purification of cloned human alpha-fetoprotein |
05/10/1994 | USRE34606 Modified enzymes and methods for making same |
05/10/1994 | US5310883 Stabilized versions of glu-3,5-basic FGF having eliminated disulfide scrambled forms; wound healing agents; promoters of angiogenesis, neutrotropism and chemotaxis |
05/10/1994 | US5310882 Somatotropins with alterations in the α-helix 3 region |
05/10/1994 | US5310876 Expression of HIV1 and HIV2 polypeptides and their use |
05/10/1994 | US5310873 Cyclohexapeptide compound |
05/10/1994 | US5310741 TAN-1251 compounds and their production from penicillium thomii |
05/10/1994 | US5310726 Antifungal, antiparasite, echinicandin B derivative |
05/10/1994 | US5310678 Genetic engineering, poultry |
05/10/1994 | US5310671 Vector for foreign dna and sequence for regulating thegene; vaccines |
05/10/1994 | US5310666 Process for the enantioselective preparation of (β-1)-hydroxyalkylxanthines by reduction using Rhodotorula rubra |
05/10/1994 | US5310665 Modifying by substituting a diffferent amino acid from that occuring in at least one position of natural isomerase |
05/10/1994 | US5310663 Affinity peptides |
05/10/1994 | US5310662 Receptors: their identification, characterization, preparation and use |
05/10/1994 | US5310660 Method and a hybrid promoter for controlling exogenous gene transcription |
05/10/1994 | US5310659 GL-7ACA acylase |
05/10/1994 | US5310654 Method for determining virulence of Yersinia |
05/10/1994 | CA1329373C Process for recovering refractile bodies containing heterologous proteins from microbial hosts |
05/06/1994 | CA2103932A1 Stereoselective reduction of ketones |
05/06/1994 | CA2102256A1 Drug resistance-conferring protein, antibodies reactive therewith and utilities thereof |
05/04/1994 | EP0595659A2 Extracellular matrix receptor ligands that modulate leukocyte function |
05/04/1994 | EP0595476A2 Dictyostelium dipeptidylaminopeptidase |
05/04/1994 | EP0595458A1 Novel thiomarinol derivatives, and processes for their preparation |
05/04/1994 | EP0595334A2 Mutant AOX2 promoter, vector carrying same, transformant, and production of heterologous protein |
05/04/1994 | EP0595167A1 Specific genetic probe and method for candida albicans diagnosis |
05/04/1994 | EP0595163A1 Process for producing L-isoleucine |
05/04/1994 | EP0594847A1 Dna coding for human fk506-binding protein and expression thereof |
05/04/1994 | EP0594843A1 Antibody assay for amylin |
05/04/1994 | EP0594771A1 Nucleotide sequences and resistance proteins cycloheximide |
05/04/1994 | EP0594732A1 Humanized antibody against cd18 |
05/04/1994 | EP0594710A1 Tyrosine kinase |
05/04/1994 | EP0594678A1 Production of polyalkanoate |
05/04/1994 | EP0594631A1 Bordetella bronchiseptica outer membrane antigen |
05/04/1994 | EP0594621A1 Process for enzymatically preparing enantiomer-free esters and alcohols |
05/04/1994 | EP0594610A1 PROTEIN D - AN IgD-BINDING PROTEIN OF HAEMOPHILUS INFLUENZAE |
05/04/1994 | EP0594576A1 Immunoassays for and monoclonal antibodies to prothrombin activation peptides and their degradation products |
05/04/1994 | EP0516655B1 Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine |
05/04/1994 | EP0514413B1 Immunologically active peptides or polypeptides from the parvovirus b19 |
05/04/1994 | EP0413695B1 Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3. |
05/04/1994 | EP0401249B1 Encapsulated bacterium |
05/04/1994 | EP0229046B1 Method for obtaining dna, rna, peptides, polypeptides or proteins by means of a dna recombinant technique |
05/03/1994 | US5308770 Cloning and overexpression of glucose-6-phosphate dehydrogenase from Leuconostoc dextranicus |
05/03/1994 | US5308759 Production of zeaxanthin and zeaxanthin-containing compositions |
05/03/1994 | US5308750 Binders for hepatitis C virus and hybridomas and antigens |
05/03/1994 | CA1329308C Process for recovering refractile bodies containing heterologous proteins from microbial hosts |
05/03/1994 | CA1329162C Process for inducing cytochrome p-450 enzymes in streptomyces bacteria and determining the mutagenicity of chemicals |
05/03/1994 | CA1329161C Process for the preparation of difructose dianhydride iii |
05/03/1994 | CA1329160C Process for the preparation of a macrocyclic compound |
05/03/1994 | CA1329157C Method for activating gene technologically produced, heterologous, eucaryotic proteins comprising disulphide bridges after expression in procaryotes |
05/03/1994 | CA1329156C Immunoglobulin conjugates |
05/01/1994 | CA2109398A1 Extracellular matrix receptor ligands that modulate leukocyte function |
04/28/1994 | WO1994009148A1 Process for producing major histocompatibility antigen class ii protein and material having the same immobilized thereon |
04/28/1994 | WO1994009147A1 Fo-1289 substance and its production |
04/28/1994 | WO1994009138A1 Interleukin-6 receptor antagonists |
04/28/1994 | WO1994009136A1 Recombinant humanized anti-cytomegalovirus antibodies |
04/28/1994 | WO1994009134A2 Modified ciliary neurotrophic factors |
04/28/1994 | WO1994009133A1 Protein partner screening assays and uses thereof |
04/28/1994 | WO1994009131A1 Recombinant specific binding protein |
04/28/1994 | WO1994009130A1 Polypeptides (5ht2c) having a serotoninergic receptor activity and uses thereof |
04/28/1994 | WO1994009124A1 Dna compounds comprising sequences encoding mannuronan c-5-epimerase |
04/28/1994 | WO1994009115A1 METHOD OF CLONAL GROWTH OF $i(STREPTOCOCCUS PNEUMONIAE) |
04/28/1994 | WO1994009114A1 New bacterium causing poultry disease and vaccine derived thereof |
04/28/1994 | WO1994009037A1 A NEW CLASS OF RPTPases: THEIR STRUCTURAL DOMAINS AND LIGANDS |
04/28/1994 | WO1994009032A1 Methods and compositions for detecting anti-hepatitis e virus activity |
04/28/1994 | WO1994009023A1 THE tagA GENE AND METHODS FOR DETECTING PREDISPOSITION TO PEPTIC ULCERATION |
04/28/1994 | WO1994008933A1 Antibiotic agents |
04/28/1994 | WO1994008738A1 Anthraquinone inhibition of methane production in methanogenic bacteria |
04/28/1994 | WO1994008609A1 TREATMENT OF INSULIN RESISTANCE IN OBESITY LINKED TYPE II DIABETES USING ANTAGONISTS TO TNF-α FUNCTION |
04/28/1994 | WO1994008467A1 Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids |
04/28/1994 | DE4244715A1 Isolation of circulating cancer cells from bloodstream |
04/28/1994 | DE4228457A1 Herstellung von heterodimerem PDGF-AB mit Hilfe eines bicistronischen Vektorsystems in Säugerzellen Production of heterodimeric PDGF-AB using a bicistronic vector system in mammalian cells |
04/28/1994 | CA2147622A1 Methods and compositions for detecting anti-hepatitis e virus activity |
04/28/1994 | CA2147466A1 Interleukin-6 receptor antagonists |
04/28/1994 | CA2147180A1 Treatment of insulin resistance in obesity linked type ii diabetes using antagonists to tnf-.alpha. function |
04/28/1994 | CA2147167A1 A new class of rptpases: their structural domains and ligands |
04/28/1994 | CA2146862A1 The taga gene and methods for detecting predisposition to peptic ulceration |
04/28/1994 | CA2146855A1 Recombinant humanized anti-cytomegalovirus antibodies |
04/28/1994 | CA2146854A1 Recombinant specific binding protein |
04/28/1994 | CA2146766A1 Polypeptides with a serotoninergic receptor activity (5ht2c) and uses therefor |
04/28/1994 | CA2146129A1 Method of clonal growth of streptococcus pneumoniae |
04/28/1994 | CA2145204A1 Antibiotic agents |
04/28/1994 | CA2125871A1 Process for preparing major histocompatibility antigen class ii protein and materials in which the same is bound |
04/27/1994 | EP0594311A1 Metastasis-inhibiting protein, and DNA encoding said protein |
04/27/1994 | EP0594235A2 Method of purification of amylase, purified amylase so obtained and uses of purified amylase |
04/27/1994 | EP0594099A1 Process for the purification of crude clavulanic acid |
04/27/1994 | EP0593857A1 Biologically active porcine somatotropin polypeptides and methods of using the same |
04/27/1994 | EP0593794A1 Isolated mink growth hormone genes, novel recombinant DNA and methods for producing mink growth hormone |
04/27/1994 | EP0593755A1 Defective recombinant adenoviruses expressing cytokines for use in antitumoral treatment |
04/27/1994 | EP0593620A1 Herpes virus proteinase and method of assaying |
04/27/1994 | EP0593516A1 Methods of treatment of motor neuron diseases using members of the bdnf/nt-3/ngf family of molecules |
04/27/1994 | EP0593428A1 Myconematicide |
04/27/1994 | CN1085957A Oligonucleotides derived from the SOD family |